Study tests combination of taxanes with an angiogenesis inhibitor in search for better outcomes for patients with advanced KRAS-mutated NSCLC. Read more
During an interview with ILCN, Drs. Paul Paik and Jonathan Reiss discuss the implications of KEAP1 and NFE2L2 mutations in NSCLC. Read more
Practical aspects of clinically managing operable SABR patients are important for the long-term care of this unique population. Read more
Lung cancer specialists are slowly being faced with the challenge of how to balance the benefits of next-generation tumor tissue testing against those of liquid biopsy in the clinic. During […] Read more
Nurses are an essential part of the revolution of personalized care occurring in oncology. During the 2021 International Society of Liquid Biopsy (ISLB) Congress, Allison Gittens, BSN, RN, OCN, a […] Read more
To increase access to radiotherapy worldwide, new guidance from the WHO and IAEA includes a prioritized list of medical devices for cancer management. Read more
Dr. Rodriguez de Dios talks with ILCN about the implications of the PREMER study, a phase III trial comparing PCI with and without hippocampal avoidance in SCLC. Read more
See how specialists in France use MTBs to develop the most beneficial treatment strategies for patients and to decrease inequity in cancer care. Read more
Study findings suggest that a significant number of unplanned hospital visits for patients with lung cancer might be avoidable. Read more
Study shows emerging techniques may improve prognostic and predictive models in identifying patients at risk for early weight loss. Read more